DH - Definitive Healthcare Corp. Forward P/S Multiple

Corporate emblem and logo of Definitive Healthcare Corp. (DH)

Definitive Healthcare is expanding its healthcare data IT analytics through partnerships with pharmaceutical giants and the acquisition of AI startups. The forward P/S ratio reflects market expectations, where 0.60 shapes the current metric. Growth is driven by clinics' need for strategy optimization and the implementation of predictive models. The cloud service scales via AI-driven customer acquisition algorithms, ensuring high subscriber loyalty.

DH (definitivehc.com) Forward Price to Sales history from 07/04/2022 to 11/13/2026

DH (Definitive Corp): analytical breakdowns and indicator data

- stock price and consensus target price:
Fundamental company analysis:DH (Definitive Healthcare Corp.)
Product sample of Definitive Corp

Definitive Healthcare's unique medical data linking algorithms create high switching costs for clients, ensuring a sustainable competitive advantage. The forward P/S ratio digitizes this value by comparing current market capitalization with expected future revenue volumes. This indicator measures the premium the market is willing to pay for potential business growth between quarterly reports. Analyzing the forward P/S chart allows an investor to objectively assess the asset's degree of overvaluation.

Who Definitive Healthcare competes with

Veeva - Forward Price-to-Revenue Multiple|Doximity Inc - Price-to-Projected Revenue Ratio|HealthEquity Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio Waystar Corp|CRVL (CorVel Corporation) - Forward Price-to-Revenue Multiple|priviahealth.com - Forward Price to Sales|HURN (Huron) - Forward P/S Multiple|CERT: Forward Price to Sales|Forward P/S Multiple OMCL|GDRX - Market Cap to Future Revenue Ratio|Forward P/S Multiple SDGR (Schrodinger, Inc.)|Forward P/S Multiple phreesia.com PHR|OMDA - Price-to-Projected Revenue Ratio|EVH: Price-to-Projected Revenue Ratio|HSTM (HealthStream Corp) - Forward Price-to-Revenue Multiple|CCSI: Price to Expected Revenue Ratio|AGL (Agilon Health) - Forward P/S Multiple|ABSI: Forward Price to Sales|Forward P/S Multiple SY|Forward Price-to-Revenue Multiple NRC Health NRC|Forward P/S Multiple SPOK (Spok Corp)|Forward P/S Multiple OptimizeRx Inc. OPRX|TBRG - Price-to-Projected Revenue Ratio|Forward Price to Sales SLP (simulations-plus.com)|SOPH: Forward P/S Multiple|Market Cap to Future Revenue Ratio Health Catalyst Inc. (HCAT)|CCLD (CareCloud Inc.) - Forward P/S Multiple|Market Cap to Projected Revenue RSSS (Research Solutions Inc.)|Forward P/S Multiple DLHC|ONMD (onemednet.com) - Forward Price to Sales|Forward P/S Multiple SCNX (Scienture)|Market Cap to Expected Sales Ratio Healthcare Triangle Inc (HCTI)|ISPC: Forward Price-to-Revenue Multiple|Bullfrog AI Holdings - Price to Expected Revenue Ratio|WORX (SCWorx Corp.) - Forward Price-to-Revenue Multiple|msprecovery.com - Forward Price to Sales|Price-to-Projected Revenue Ratio iCoreConnect, Inc.|Forward Price-to-Revenue Multiple TRxADE HEALTH Inc (MEDS)|Forward P/S Multiple ORGS|RCM - Market Cap to Future Revenue Ratio|Forward P/S Multiple SHCR (Sharecare, Inc.)|STRM: Market Cap to Projected Revenue|Syra Health - Forward P/S Multiple|AMEH (Apollo Medical Holdings) - Market Cap to Projected Revenue|MODN: Forward P/S Multiple|Market Cap to Future Revenue Ratio NextGen Healthcare Corp (NXGN)